Mar 17, 2026 07:06AM
Mar 17, 2026 05:22AM
Mar 2, 2026 06:43AM
Mar 1, 2026 12:30PM
Mar 1, 2026 12:30PM
Feb 27, 2026 06:54AM
Feb 26, 2026 12:21PM Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)
Feb 26, 2026 07:00AM
Feb 18, 2026 04:30PM
Jan 9, 2026 01:08PM
Jan 9, 2026 08:02AM
Jan 9, 2026 08:00AM
Dec 17, 2025 06:45AM
Nov 7, 2025 02:06PM Rhythm Pharmaceuticals (RYTM) PT Lowered to $141 at Goldman Sachs
Nov 7, 2025 07:30AM
Nov 7, 2025 07:30AM
Nov 4, 2025 07:00AM
Sep 29, 2025 06:56AM
Sep 25, 2025 06:50AM
Sep 25, 2025 05:12AM
Sep 25, 2025 04:02AM Rhythm Pharmaceuticals (RYTM) PT Raised to $157 at Goldman Sachs
Sep 24, 2025 03:42PM
Aug 20, 2025 04:01PM
Aug 20, 2025 04:01PM
Dec 19, 2024 09:42AM
Dec 3, 2024 06:00AM
Nov 13, 2024 06:30PM
Nov 13, 2024 06:30PM Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
Nov 5, 2024 04:01PM
Aug 26, 2024 08:02AM
Aug 26, 2024 08:02AM
Jun 13, 2022 08:00AM
Jun 13, 2022 08:00AM
Jun 13, 2022 08:00AM
Jun 13, 2022 08:00AM Rhythm Pharmaceuticals Presents Initial Data from Long-term Extension Trial Evaluating Setmelanotide in Rare Genetic Diseases of Obesity at ENDO 2022
Jun 2, 2022 04:01PM
Jun 2, 2022 04:01PM
May 5, 2022 04:01PM
May 5, 2022 04:01PM
May 4, 2022 08:00AM
May 4, 2022 08:00AM
May 3, 2022 07:00AM Rhythm Pharmaceuticals Reports First Quarter 2022 Financial Results and Business Update
May 3, 2022 07:00AM
May 2, 2022 08:00AM
May 2, 2022 08:00AM
Apr 26, 2022 08:00AM
Apr 26, 2022 08:00AM
Apr 8, 2022 08:00AM
Apr 8, 2022 08:00AM Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Apr 6, 2022 08:02AM

15,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All